T cell-dependent production of IFN-γ by NK cells in response to influenza a virus

Journal of Clinical Investigation

Volumn 114, Issue 12, 2004, Pages 1812-1819

  He, Xiao Song ^a,c   Draghi, Monia ^a   Mahmood, Kutubuddin ^b   Holmes, Tyson H ^a   Kemble, George W ^b   Dekker, Cornelia L ^a   Arvin, Ann M ^a   Parham, Peter ^a   Greenberg, Harry B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDIMMUNE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD56 ANTIGEN; GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; BREFELDIN A; CD3 ANTIGEN; INTERLEUKIN 2; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA VIRUS A; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PURIFICATION; RECURRENT INFECTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DOG; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; ORTHOMYXOVIRUS; TIME; VIROLOGY;

ADULT; AGED; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD56; BREFELDIN A; CELL LINE; DOGS; FLOW CYTOMETRY; HUMANS; INFLUENZA A VIRUS; INTERFERON TYPE II; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; ORTHOMYXOVIRIDAE; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TIME FACTORS;

EID: 85047689873     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22797     Document Type: Article

References (58)

1. Lamb, R.A., and Krug, R.M. 2001. Orthomyxoviridae: the viruses and their replication. In Fields virology. D.M. Knipe and P.M. Howley, editors. Lippincott Williams & Wilkins. Philadelphia, Pennsylvania, USA. 1533-1579.
2. Yap, K.L., Ada, G.L., and McKenzie, I.F. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 273:238-239.
3. McMichael, A.J., Gotch, F.M., Noble, G.R., and Beate, P.A. 1983. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:13-17.
4. Doherty, P.C., et al. 1997. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105-117.
5. Graham, M.B., and Braciale, T.J. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186:2063-2068.
6. Benton, K.A., et al. 2001. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J. Immunol. 166:7437-7445.
7. Dong, L., Mori, I., Hossain, M.J., and Kimura, Y. 2000. The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J. Infect. Dis. 182:391-396.
8. Liu, B., et al. 2004. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 85:423-428.
9. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
10. Robertson, M.J., and Ritz, J. 1990. Biology and clinical relevance of human natural killer cells. Blood. 76:2421-2438.
11. Tay, C.H., Szomolanyi-Tsuda, E., and Welsh, R.M. 1998. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230:193-220.
12. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P., and Salazar-Mather, T.P. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Anna. Rev. Immunol. 17:189-220.
13. Cooper, M.A., Fehniger, T.A., and Caligiuri, M.A. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
14. Magier, A., Lanier, L.L., Cwirla, S., and Phillips, J.H. 1989. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143:3183-3191.
15. Cooper, M.A., et al. 2001. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 97:3146-3151.
16. Fehniger, T.A., et al. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 101:3052-3057.
17. Fernandez-Botran, R., Sanders, V.M., Mosmann, T.R., and Vitetta, E.S. 1988. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J. Exp. Med. 168:543-558.
18. Gajewski, T.F., Goldwasser, E., and Fitch, F.W. 1988. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor. J. Immunol. 141:2635-2642.
19. Parronchi, P., et al. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development: of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977-2983.
20. Maggi, E., et al. 1992. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 148:2142-2147.
21. Bradley, L.M., Dalton, O.K., and Croft, M. 1996. A direct role for IFN-gamma in regulation of Th1 cell development. J. Immunol. 157:1350-1358.
22. Guidotti, L.G., and Chisari, F.V. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
23. Frese, M., et al. 2002. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology. 35:694-703.
24. Cheney, I.W., et al. 2002. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J. Virol. 76:11148-11154.
25. Lanford, R.E., et al. 2003. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J. Virol. 77:1092-1104.
26. He, X.S., et al. 2003. Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J. Infect. Dis. 187:1075-1084.
27. Jacobs, R., et al. 2001. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J. Immunol. 31:3121-3127.
28. Carnaud, C., et al. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650.
29. Biron, C.A., Young, H.A., and Kasaian, M.T. 1990. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171:173-188.
30. Cooper, M.A., et al. 2001. Interleukin-1 beta costimulates interferon-gamma production by human natural killer cells. Eur. J. Immunol. 31:792-801.
31. Smith, K.A. 1988. Interleukin-2: inception, impact, and implications. Science. 240:1169-1176.
32. Orange, J.S., and Biron, C.A. 1996. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral scare and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
33. Orange, J.S., and Biron, C.A. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138-1142.
34. Robertson, M.J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71:173-183.
35. Campbell, J.J., et al. 2001. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166:6477-6482.
36. Frey, M., et al. 1998. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 161:400-408.
37. Ferlazzo, G., et al. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:1455-1462.
38. Weis, W., et al. 1988. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature. 333:426-431.
39. Ronni, T., Sareneva, T., Pirhonen, J., and Julkunen, I. 1995. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154:2764-2774.
40. Bender, A., et al. 1998. The distinctive features of influenza virus infection of dendritic cells. Immunobiology. 198:552-567.
41. Coccia, E.M., et al. 2004. Viral infection and Toll-like receptor agonists induce a differencial expression of type I and lambda interferons in human plasmacycoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34:796-805.
42. Decker, T., Stockinger, S., Karaghiosoff, M., Müller, M., and Kovarik, P. 2002. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 109:1271-1277. doi: 10.1172/JCI200215770.
43. Larsson, M., et al. 2000. Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. J. Immunol. 165:1182-1190.
44. Fonteneau, J.F., et al. 2003. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood. 101:3520-3526.
45. Scharton-Kersten, T., Afonso, L.C., Wysocka, M., Trinchieri, G., and Scott, P. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
46. Zhang, T., et al. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65:3594-3599.
47. Mailliard, R.B., et al. 2002. Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses. J. Exp. Med. 195:473-483.
48. Medzhitov, R., and Janeway, C.A., Jr. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9.
49. Ferlazzo, G., et al. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343-351.
50. Gerosa, F., et al. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327-333.
51. Piccioli, D., Sbrana, S., Melandri, E., and Valiante, N.M. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:335-341.
52. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195:F9-F14.
53. Moretta, A. 2002. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2:957-964.
54. Liu, Z.X., Govindarajan, S., Okamoto, S., and Dennert, G. 2000. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity co a viral liver infection. J. Immunol. 164:6480-6486.
55. Kos, F.J., and Engleman, E.G. 1996. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell. Immunol. 173:1-6.
56. Lennette, D.A. 1995. General principles for laboratory diagnosis of viral, rickectsial, and chlamydial infections. In Diagnostic procedures for viral, rickettsial, and chlamydial infections. E.H. Lennette, D.A. Lennette, and E.T. Lennette, editors. American Public Health Association. Washington, D.C., USA. 3-25.
57. Daniel, W.W. 1990. Applied nonparatnetric statistics. PWS-Kent. Boston, Massachusetts, USA. 358-363.
58. Rice, W.R. 1989. Analyzing tables of statistical tests. Evolution. 43:223-225.